These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 7307341

  • 1. Ability of complement to release systemic lupus erythematosus immune complexes from cell receptors.
    Medof ME, Scarborough D, Miller G.
    Clin Exp Immunol; 1981 May; 44(2):416-25. PubMed ID: 7307341
    [Abstract] [Full Text] [Related]

  • 2. Restoration of normal interactions between immune complexes and systemic lupus erythematosus blood cells by normal serum.
    Medof ME, Oger JJ, Antel JP, Prince GM.
    J Clin Lab Immunol; 1982 Feb; 7(2):93-103. PubMed ID: 7069786
    [Abstract] [Full Text] [Related]

  • 3. Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus.
    Anderson CL, Stillman WS.
    J Clin Invest; 1980 Aug; 66(2):353-60. PubMed ID: 6995484
    [Abstract] [Full Text] [Related]

  • 4. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM, Alves CM, Azzolini AE, Polizello AC, Carvalho IF, Lucisano-Valim YM.
    J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
    [Abstract] [Full Text] [Related]

  • 5. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
    Gupta RC, McDuffie FC, Tappeiner G, Jordon RE.
    Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
    [Abstract] [Full Text] [Related]

  • 6. The Raji cell radioimmune assay for detecting immune complexes in human sera.
    Theofilopoulos AN, Wilson CB, Dixon FJ.
    J Clin Invest; 1976 Jan; 57(1):169-82. PubMed ID: 128562
    [Abstract] [Full Text] [Related]

  • 7. The effect of sera of patients with systemic lupus erythematosus on artificial immune complexes.
    Bányai A, Szabó G, Csongor J, Sonkoly I, Szegedi G.
    Acta Med Hung; 1985 Jan; 42(1-2):51-7. PubMed ID: 4034337
    [Abstract] [Full Text] [Related]

  • 8. The kinetics of [3H]-dsDNA/anti-DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess.
    Horgan C, Burge J, Crawford L, Taylor RP.
    J Immunol; 1984 Oct; 133(4):2079-84. PubMed ID: 6332147
    [Abstract] [Full Text] [Related]

  • 9. Impaired monocyte motility in sera from patients with systemic lupus erythematosus.
    Sturfelt G, Linder C, Sjöholm AG, Svensson B.
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):151-8. PubMed ID: 6880748
    [Abstract] [Full Text] [Related]

  • 10. Competition for immune complexes by red cells in human blood.
    Medof ME, Oger JJ.
    J Clin Lab Immunol; 1982 Jan; 7(1):7-13. PubMed ID: 7069779
    [Abstract] [Full Text] [Related]

  • 11. BSA-anti-BSA immune complexes formed in the presence of human complement do not bind to autologous red blood cells.
    Varga L, Thiry E, Füst G.
    Immunology; 1988 Jul; 64(3):381-4. PubMed ID: 3410490
    [Abstract] [Full Text] [Related]

  • 12. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.
    Zubler RH, Lange G, Lambert PH, Miescher PA.
    J Immunol; 1976 Jan; 116(1):232-5. PubMed ID: 1245740
    [Abstract] [Full Text] [Related]

  • 13. Kinetics of interaction of immune complexes with complement receptors on human blood cells: modification of complexes during interaction with red cells.
    Medof ME, Prince GM, Oger JJ.
    Clin Exp Immunol; 1982 Jun; 48(3):715-25. PubMed ID: 7116690
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of polymorphonuclear leukocyte chemiluminescence for detection of immune complexes in human sera.
    Doll NJ, Wilson MR, Salvaggio JE.
    J Clin Invest; 1980 Sep; 66(3):457-64. PubMed ID: 6156953
    [Abstract] [Full Text] [Related]

  • 15. Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus.
    Marder RJ, Potempa LA, Jones JV, Toriumi D, Schmid FR, Gewurz H.
    Acta Pathol Microbiol Immunol Scand Suppl; 1984 Sep; 284():25-34. PubMed ID: 6375256
    [Abstract] [Full Text] [Related]

  • 16. Circulating immune complexes in lupus erythematosus, scleroderma and dermatomyositis.
    Sølling J, Sølling K, Jacobsen KU.
    Acta Derm Venereol; 1979 Sep; 59(5):421-6. PubMed ID: 93365
    [Abstract] [Full Text] [Related]

  • 17. C4A deficiency and elevated level of immune complexes: the mechanism behind increased susceptibility to systemic lupus erythematosus.
    Traustadottir KH, Sigfusson A, Steinsson K, Erlendsson K.
    J Rheumatol; 2002 Nov; 29(11):2359-66. PubMed ID: 12415592
    [Abstract] [Full Text] [Related]

  • 18. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T, Fujita T, Kono I, Kabashima T, Yamane K, Tamura N, Kashiwagi H.
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [Abstract] [Full Text] [Related]

  • 19. Fate of immune complexes, glomerulonephritis, and cell-mediated vasculitis in lupus-prone MRL/Mp lpr/lpr mice.
    Cruse JM, Lewis RE, Dilioglou S.
    Exp Mol Pathol; 2000 Dec; 69(3):211-22. PubMed ID: 11115362
    [Abstract] [Full Text] [Related]

  • 20. Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis.
    Schifferli JA, Morris SM, Dash A, Peters DK.
    Clin Exp Immunol; 1981 Dec; 46(3):557-64. PubMed ID: 7337980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.